Nitzan Rosenfeld receives Translational Research Award
Congratulations to Nitzan Rosenfeld, who has won the 2013 British Association for Cancer Research Translational Research Award.
The purpose of the award is to recognise and reward the achievements of an individual whose work has made significant contributions to translational (laboratory – clinic) cancer research.
The lab are working on developing effective methods to make use of circulating tumour DNA (ctDNA), which is found in blood and other body fluids and contains much useful information about a patient’s cancer. For example, by using genomic techniques to study ctDNA researchers can learn about the evolution of a patient’s tumour and how it is developing resistance to therapy. The advantage of using ctDNA to diagnose and monitor disease is that it can be collected relatively non-invasively, through a blood test rather than a tumour biopsy, and ease of sample collection means that you can take many more samples to follow the development and changes in a tumour.
Related News
See all news-
New immune pathway offers treatment hope for childhood brain tumours
3rd February 2026
A newly discovered immune pathway could lead to gentler treatments for multiple childhood brain cancers, according to new research from our Gilbertson Group published today in Nature Genetics.
Find out more -
Targeting paused cells could improve chemotherapy for lung and ovarian cancers
3rd February 2026
New research published today in Nature Aging by scientists at the University of Cambridge sheds light on why some lung and ovarian cancers stop responding to chemotherapy, and how this resistance might one day be prevented.
Find out more -
Hot flush treatment has anti-breast cancer activity, study finds
5th January 2026
A drug mimicking the hormone progesterone has anti-cancer activity when used together with conventional anti-oestrogen treatment for women with breast cancer, a new Cambridge-led trial has found.
Find out more